GSHD vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GSHD presents a precarious profile with a Piotroski F-Score of 4/9, indicating only stable financial health. The stock is experiencing a severe valuation crisis, trading at $40.49 despite a growth-based intrinsic value of $7.28 and a negative Price-to-Book ratio (-10.45). While revenue continues to grow at 12.2%, earnings growth has turned negative (-15.7% YoY), and the price has collapsed by 63.5% over the last year. The massive divergence between the current price and intrinsic value, coupled with negative equity, outweighs the optimistic analyst target prices.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
GSHD vs JPM: Head-to-Head Comparison
This page compares Goosehead Insurance, Inc. (GSHD) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.